IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MWG Management Ltd.

Q1 2025 Holdings

Filed 2025-05-13 | 3 holdings | $58.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Beam Therapeutics Inc(BEAM)COM07373V105$44.3M2,266,93475.4%
Lyell Immunopharma IncCOM55083R104$10.8M20,162,33218.5%
Prime Medicine Inc(PRME)COM74168J101$3.6M1,792,2106.1%